Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Dinney

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Seminars in Urologic Oncology|May 1, 1996
The role of chemotherapy in the management of the patient with T3b bladder cancerR Millikan, C P Dinney
The Journal of Urology|May 1, 1990
Contralateral pleural effusion secondary to nonmetastatic renal cell carcinomaC P Dinney, R W Norman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 22, 2001
The role of angiogenesis in prostate and other urologic cancers: a reviewJ I Izawa, C P Dinney
Urologic Oncology|January 14, 2011
Markers of bladder cancer State of the artH B Grossman, C P Dinney
Seminars in Urologic Oncology|May 1, 1996
Radical cystectomy for stage T3b bladder cancerC M Hall, C P Dinney
Critical Reviews in Oncology/Hematology|July 10, 2003
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor familyJ Bellmunt, M Hussain, C P Dinney
The Journal of Urology|February 1, 1996
The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureterP Kenworthy, S Tanguay, C P Dinney
The Urologic Clinics of North America|August 3, 2010
Controversies in ilioinguinal lymphadenectomyP K Hegarty, C P Dinney, C A Pettaway
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for superficial bladder cancerC J Rosser, W F Benedict, C P Dinney
Urology|June 1, 1996
Complications of radical cystectomy: impact of the timing of perioperative chemotherapyM C Hall, D A Swanson, C P Dinney
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Seminars in Urologic Oncology|May 1, 1996
The role of chemotherapy in the management of the patient with T3b bladder cancerR Millikan, C P Dinney
The Journal of Urology|May 1, 1990
Contralateral pleural effusion secondary to nonmetastatic renal cell carcinomaC P Dinney, R W Norman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 22, 2001
The role of angiogenesis in prostate and other urologic cancers: a reviewJ I Izawa, C P Dinney
Urologic Oncology|January 14, 2011
Markers of bladder cancer State of the artH B Grossman, C P Dinney
Seminars in Urologic Oncology|May 1, 1996
Radical cystectomy for stage T3b bladder cancerC M Hall, C P Dinney
Critical Reviews in Oncology/Hematology|July 10, 2003
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor familyJ Bellmunt, M Hussain, C P Dinney
The Journal of Urology|February 1, 1996
The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureterP Kenworthy, S Tanguay, C P Dinney
The Urologic Clinics of North America|August 3, 2010
Controversies in ilioinguinal lymphadenectomyP K Hegarty, C P Dinney, C A Pettaway
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for superficial bladder cancerC J Rosser, W F Benedict, C P Dinney
Urology|June 1, 1996
Complications of radical cystectomy: impact of the timing of perioperative chemotherapyM C Hall, D A Swanson, C P Dinney
Pageof 8